FILTER BY:
Although greatly improved by anti-VEGF therapy, the treatment of patients …
Expiration Date: 6/29/2023
Max Credits: 1.25
View Activity
Treatment burden and suboptimal responses observed in patients receiving i…
Uveitic macular edema (UME) is the most common cause of vision loss in pat…
Expiration Date: 6/22/2023
Max Credits: 0.5
The need to identify alternate molecular targets for the management of ret…
Expiration Date: 5/24/2023
Max Credits: 1
Optimization of visual outcomes for patients with retinal diseases continu…
Expiration Date: 3/20/2023
The advanced form of age-related macular degeneration (AMD), geographic at…
Expiration Date: 3/15/2023
Max Credits: 0.75
Diabetic macular edema (DME) is a leading cause of visual impairment. Whil…
Expiration Date: 3/7/2023
Significant visual and anatomic improvements through the integration of in…
X-linked retinitis pigmentosa (XLRP) is a rare, inherited retinal disease …
Expiration Date: 2/27/2023
Intravitreal therapy has rapidly evolved to become a mainstay of treatment…